Posted on 11/17/2021 10:14:12 AM PST by SeekAndFind
I remember when it took more than “weeks” to get a new medicine approved.
yeah but now they grease the skids or palms and voila...
Maybe it’s too bad that some of the Regulators aren’t grown up Thalidomide babies — no palms to grease.
SOME Q&A about the Novavax Covid vaccine:
SOURCE:
Q: When can I get a Novavax coronavirus vaccine?
A: The vaccine, called NVX-CoV2373, is not currently available in the United States. The company expects to submit data to the Food and Drug Administration by the end of the year. Once authorization is requested, a rigorous review process will take place before the shot is cleared for use in the general public.
Q: What makes this coronavirus vaccine different from the ones we already have?
A: The Novavax vaccine is protein-based and uses the same platform as shots for shingles and hepatitis. The proteins deliver immune stimulation directly into a person’s cells as opposed to a fragment of genetic code. It is not an mRNA as is the case with Moderna and Pfizer, or an adenovirus vector, such as the Johnson & Johnson vax.
Q: How does it work?
A: The Novavax coronavirus vaccine is engineered from the genetic sequence of coronavirus with nanoparticle technology. The technology binds with human receptors targeted by virus which is critical for effective protection. When the vaccine is injected, it stimulates the immune system to produce antibodies.
Q: Is it safe and effective?
A: Clinical trials for the Novavax shot have shown an overall 90% efficacy against coronavirus and 100% protection against moderate and severe disease. Most common side effects include injection site pain and tenderness, fatigue, headache and muscle pain. No single adverse reaction was reported by more than 1% of trial participants.
Q: Can foreign travelers show proof of the Novavax vaccine to enter the United States?
A: Yes. Novavax clinical trial participants from sites outside the U.S. are considered fully vaccinated if they received the same product that was administered in the U.S. clinical trials. It is one of the vaccines already approved by the Centers for Disease Control and Prevention for air travel in the U.S., giving the 30,000 in the trial for the jab a passport to move around, whereas other shots haven’t made the cut.
Q: Could children get this vaccine?
A: The vaccine is not yet authorized for use in the United States, but Novavax initiated a pediatric expansion of a phase 3 clinical trial in May 2021 for children ages 12-17. The company intends to pursue authorization in that age group and younger age groups.
Q: How is it administered?
A: Two doses are given three weeks apart.
excellent point!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.